RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기
    KCI등재

    혈구포식 림프조직구증식증 = Hemophagocytic Lymphohistiocytosis

    한글로보기

    https://www.riss.kr/link?id=A105119863

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal disease caused by dysregulated immune responses and overwhelming inflammation to infectious or other triggers of the immune system. HLH may be inherited (primary) or may be secondary to any severe infection, malignancy or rheumatologic disease. Clinical progress of HLH is usually rapid and fatal. Early recognition and assessment of potential causes of HLH is critical to improve survival. Urgent treatment is needed for immunosuppression and degradation of the activated antigen. Over the last two decades, research on genetics and pathophysiology of HLH has much improved treatment outcome of the patient. Here, we review recent advances in our understanding of etiology, pathophysiology, diagnosis and treatment of HLH.
    번역하기

    Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal disease caused by dysregulated immune responses and overwhelming inflammation to infectious or other triggers of the immune system. HLH may be inherited (primary) or may be secondary to a...

    Hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal disease caused by dysregulated immune responses and overwhelming inflammation to infectious or other triggers of the immune system. HLH may be inherited (primary) or may be secondary to any severe infection, malignancy or rheumatologic disease. Clinical progress of HLH is usually rapid and fatal. Early recognition and assessment of potential causes of HLH is critical to improve survival. Urgent treatment is needed for immunosuppression and degradation of the activated antigen. Over the last two decades, research on genetics and pathophysiology of HLH has much improved treatment outcome of the patient. Here, we review recent advances in our understanding of etiology, pathophysiology, diagnosis and treatment of HLH.

    더보기

    참고문헌 (Reference)

    1 Yoon HS, "UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis" 95 : 622-626, 2010

    2 Henter JI, "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation" 100 : 2367-2373, 2002

    3 Fischer A, "Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation" 76 : 263-268, 1985

    4 Stéphan JL, "Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A" 82 : 2319-2323, 1993

    5 Lilleyman JS, "The treatment of familial erythrophagocytic lymphohistiocytosis" 46 : 468-470, 1980

    6 Ambruso DR, "Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213" 45 : 2516-2520, 1980

    7 Henter JI, "Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis" 2 : 1402-, 1986

    8 Stinchcombe JC, "Secretory mechanisms in cell-mediated cytotoxicity" 23 : 495-517, 2007

    9 Marsh RA, "Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab" 60 : 101-109, 2013

    10 Schechter T, "Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens" 10 : 1101-1106, 2014

    1 Yoon HS, "UNC13D is the predominant causative gene with recurrent splicing mutations in Korean patients with familial hemophagocytic lymphohistiocytosis" 95 : 622-626, 2010

    2 Henter JI, "Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation" 100 : 2367-2373, 2002

    3 Fischer A, "Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation" 76 : 263-268, 1985

    4 Stéphan JL, "Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A" 82 : 2319-2323, 1993

    5 Lilleyman JS, "The treatment of familial erythrophagocytic lymphohistiocytosis" 46 : 468-470, 1980

    6 Ambruso DR, "Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213" 45 : 2516-2520, 1980

    7 Henter JI, "Successful induction with chemotherapy including teniposide in familial erythrophagocytic lymphohistiocytosis" 2 : 1402-, 1986

    8 Stinchcombe JC, "Secretory mechanisms in cell-mediated cytotoxicity" 23 : 495-517, 2007

    9 Marsh RA, "Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab" 60 : 101-109, 2013

    10 Schechter T, "Risk for complications in patients with hemophagocytic lymphohistiocytosis who undergo hematopoietic stem cell transplantation: myeloablative versus reduced-intensity conditioning regimens" 10 : 1101-1106, 2014

    11 Marsh RA, "Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation" 116 : 5824-5831, 2010

    12 O'Brien MM, "Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis" 50 : 381-383, 2008

    13 Allen CE, "Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis" 2015 : 177-182, 2015

    14 Feldmann J, "Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3)" 115 : 461-473, 2003

    15 Lehmberg K, "Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents" 170 : 539-549, 2015

    16 Ravelli A, "Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis:diagnosis, genetics, pathophysiology and treatment" 13 : 289-298, 2012

    17 Ohadi M, "Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping" 64 : 165-171, 1999

    18 Henter JI, "Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis" 80 : 428-435, 1991

    19 Meeths M, "Incidence and clinical presentation of primary hemophagocytic lymphohistiocytosis in Sweden" 62 : 346-352, 2015

    20 Mahlaoui N, "Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients" 120 : e622-e628, 2007

    21 Zhang K, "Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH" 118 : 5794-5798, 2011

    22 Jordan MB, "How I treat hemophagocytic lymphohistiocytosis" 118 : 4041-4052, 2011

    23 Scott RB, "Histiocytic medullary reticulosis" 234 : 194-198, 1939

    24 Allen CE, "Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis" 50 : 1227-1235, 2008

    25 Janka GE, "Hemophagocytic lymphohistiocytosis:pathogenesis and treatment" 2013 : 605-611, 2013

    26 Chandrakasan S, "Hemophagocytic lymphohistiocytosis:advances in pathophysiology, diagnosis, and treatment" 163 : 1253-1259, 2013

    27 Aricò M, "Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society" 10 : 197-203, 1996

    28 서종진, "Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: recent advances and controversies" 대한혈액학회 50 (50): 131-139, 2015

    29 Atteritano M, "Haemophagocytic syndrome in rheumatic patients. A systematic review" 16 : 1414-1424, 2012

    30 Henter JI, "HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society" 28 : 342-347, 1997

    31 Henter JI, "HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis" 48 : 124-131, 2007

    32 Jessen B, "Graded defects in cytotoxicity determine severity of hemophagocytic lymphohistiocytosis in humans and mice" 4 : 448-, 2013

    33 Horne A, "Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis" 140 : 327-335, 2008

    34 Janka GE, "Familial hemophagocytic lymphohistiocytosis" 140 : 221-230, 1983

    35 Farquhar JW, "Familial haemophagocytic reticulosis" 27 : 519-525, 1952

    36 Gholam C, "Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management" 163 : 271-283, 2011

    37 Janka GE, "Familial and acquired hemophagocytic lymphohistiocytosis" 166 : 95-109, 2007

    38 Koh KN, "Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party" 94 : 51-59, 2015

    39 Ishii E, "Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan. Japan LCH Study Group" 30 : 276-283, 1998

    40 Trottestam H, "Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol" 118 : 4577-4584, 2011

    41 Trottestam H, "Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol" 118 : 4577-4584, 2011

    42 Henter JI, "Biology and treatment of familial hemophagocytic lymphohistiocytosis: importance of perforin in lymphocyte-mediated cytotoxicity and triggering of apoptosis" 38 : 305-309, 2002

    43 Jordan MB, "An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+T cells and interferon gamma are essential for the disorder" 104 : 735-743, 2004

    44 Marsh RA, "Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes" 121 : 877-883, 2013

    45 Fischer A, "Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis" 108 : 267-270, 1986

    46 Ramos-Casals M, "Adult haemophagocytic syndrome" 383 : 1503-1516, 2014

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2023 평가 재인증평가 신청대상 (재인증)
    2020-01-01 등재 등재학술지 선정 (재인증) KCI등재
    2019-12-01 등재 등재후보로 하락 (계속평가) KCI등재후보
    2016-01-01 등재 등재학술지 선정 (계속평가) KCI등재
    2014-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.1 0.1 0
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0 0 0 0
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼